Anzeige
Mehr »
Login
Samstag, 18.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
Letzte Chance, bevor die Bohrer dieses "Monster"-Vorkommen bei einem 13-Millionen-Unternehmen ansteuern
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D7GE | ISIN: CA10002E1060 | Ticker-Symbol: EKV
Frankfurt
17.01.25
08:06 Uhr
0,030 Euro
0,000
0,00 %
Branche
Rohstoffe
Aktienmarkt
Sonstige
1-Jahres-Chart
BORON ONE HOLDINGS INC Chart 1 Jahr
5-Tage-Chart
BORON ONE HOLDINGS INC 5-Tage-Chart
ACCESS Newswire
209 Leser
Artikel bewerten:
(1)

Boron One Holdings Inc.: Boron One Announces Successful Closing of Early Warrant Exercise Incentive Program

Finanznachrichten News

VICTORIA, BC / ACCESS Newswire / January 17, 2025 / Boron One Holdings Inc. ("Boron One" or the "Company") (TSXV:BONE) is pleased to announce the closing of its previously announces (November 22, 2024, December 9, 2024 and December 20, 2024) warrant exercise incentive program (the "Program"). The Program was designed to encourage the exercise of up to 11,576,000 unlisted common share purchase warrants of the Company (the "Eligible Warrants") which were issued in connection with its private placement of units ("Units") that closed on September 27, 2023 ("Tranche 1") and November 7, 2023 ("Tranche 2"). Each Unit was comprised of one (1) common share of the Company ("Common Share") and one (1) Eligible Warrant, entitling the holder thereof to acquire one (1) Common Share (each, a "Warrant Share") at a price of $0.07 for the first six months and $0.12 for the remaining 12 months, being March 27, 2025 for Tranche 1 Eligible Warrants and May 7, 2025 for Tranche 2 Eligible Warrants, respectively.

Pursuant to the Program, holders exercised 7,266,000 Eligible Warrants for proceeds of $435,960.00 which will be used for general working capital. Participating holders were also issued 7,266,000 additional warrants (an "Incentive Warrant"). Each Incentive Warrant entitles the holder thereof to purchase one (1) Common Share for a period of 2 years at a price of $0.06 per Common Share, subject to the right of the Company to accelerate expiry upon 30 days' notice if the Common Shares trade on the TSX Venture Exchange ("TSXV") at or above $0.10 for a period of 10 days.

Eligible Warrants that remain unexercised following the completion of the Early Exercise Period will continue to be exercisable for Common Shares on the original terms as they existed prior to the Program, with the Tranche 1 Eligible Warrants expiring on March 27, 2025, and the Tranche 2 Eligible Warrants expiring on May 7, 2025, both at 5:00 p.m. (Vancouver time).

The Incentive Warrants and any Common Shares issuable on the exercise thereof will be subject to a four-month and a-day hold period from the date of issuance of the Incentive Warrants pursuant to applicable Canadian securities laws.

The Company has relied on the exemptions from the valuation and minority shareholder approval requirements of Multilateral Instrument 61-101 in sections 5.5(a) and 5.7(a) thereof and with respect of such insider participation.

The Program is subject to approval from the TSXV and is subject to receipt of all final regulatory approvals, including final approval of the TSXV. The number of Eligible Warrants exercised by insiders of the Company was 8.26% of the total Eligible Warrants.

About Boron One Holdings Inc.

Boron One Holdings Inc. is an international mineral exploration and development company with boron assets in Serbia. Headquartered in Victoria, B.C., Canada, Boron One's shares are traded on the TSXV under the symbol "BONE". For detailed information please see Boron One's website at www.boronone.com or the Company's filed documents at www.sedarplus.ca

On behalf of the Board of Directors,
Tim Daniels, President

For further information, please contact:
Boron One Holdings Inc.
Blake Fallis, General Manager |
Phone: 1-250- 384-1999 or 1-888-289-3746
info@boronone.com
www.boronone.com

Boron's Public Quotations:
Canada
TSX Venture: BONE
Berlin: EKV
US: SEC 12G3-2(B) #82-4432ERVFF
OTCBB: ERVFF

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Boron One Holdings Inc.



View the original press release on ACCESS Newswire

© 2025 ACCESS Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.